• No image available for this medication

    • COPIKTRA

    • QTY 28
    • 15 MG
    • Capsule

DUVELISIB (doo ve lis ib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It treats chronic lymphocytic leukemia and small lymphocytic lymphoma.

COPIKTRA Lifestyle Interactions

  • Duvelisib 15mg, Oral capsule

    • Interaction: Grapefruit juice
    • Severity: Major
    • Notes for Consumers: Do not take Duvelisib and Grapefruit Juice together without talking to your health care provider. Side effects from Duvelisib may get worse if you take Grapefruit Juice or grapefruit-containing foods.
    • Notes for Professionals: Advise patients to avoid grapefruit juice while taking duvelisib due to increased duvelisib exposure. Duvelisib is a CYP3A substrate; grapefruit juice is a strong CYP3A inhibitor. The increase in exposure to duvelisib is estimated to be approximately 2-fold when used concomitantly with strong CYP3A inhibitors such as grapefruit juice.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.